Ann: Neurizon updates on NUZ-001 IND Application, page-391

First 391 Last

Share
Profile

Follow
Quiltman

2,735 Posts.

3683

12/03/25

22:06

Post #: 78241304
Share

Originally posted by gavros: ↑

A response from MT on the investor hub to a question that someone submitted just yesterday. Sheds a bit more light on the current situation:

“Hi ND, I apologise if the shareholders are unclear about the nature of the FDA's request. As previously communicated to the market, the FDA requires additional exposure data (i.e., blood levels of NUZ-001 in rats and dogs) to ensure they have the necessary confidence that there will be no potential safety concerns for humans arising from the various toxicity studies conducted. We have been collaborating with Elanco and the FDA to establish the quickest path forward in providing this data. We have now submitted a request for advice to the FDA along with our proposed work plan to gather this information. Once we receive confirmation from the FDA that our proposed work plan is satisfactory, we will advise the market accordingly and outline a timeline for lifting the clinical hold. Please note there is no statutory timeline for the FDA to respond, but we are hopeful for a prompt reply given our recent interactions and the minor nature of our advice request.Regarding our position in the HEALEY Platform Trial, that hasn’t changed because we are confident, and so is HEALEY, about lifting the clinical hold soon. If anything, the delay has aligned our regimen more closely with upcoming additional regimens. This is a significant development for Neurizon as we need these extra regimens to run alongside ours to gain the maximum benefit (i.e. shared placebo) from the platform trial. Thanks for your question. MichaelPS. There is no real limitations as to how many regimens HEALEY can run concurrently. If the number is 4, they will run 4.”

Expand

A quick 2 second search on AI.

NUZ-001 running at 10 mg/kg body weight per day on current OLE study and proposed HEALEY Trial.
Looks like FDA is looking for some clarification on these studies around blood levels of monepantel and/or it's sulfone metabolite.

....

NUZ Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
19 Upvote

2 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 391 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.005(3.03%)		Mkt cap ! $78.76M

Open	High	Low	Value	Volume
17.0¢	17.5¢	16.0¢	$80.53K	478.6K

Buyers (Bids)

No.	Vol.	Price($)
1	8000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	907894	2

View Market Depth

No.	Vol.	Price($)
2	88000	0.165
5	120802	0.160
4	279028	0.155
3	214444	0.150
1	10000	0.145

Price($)	Vol.	No.
0.170	907895	2
0.175	29411	1
0.180	140565	4
0.185	150125	4
0.190	725092	4

Last trade - 16.10pm 26/06/2025 (20 minute delay)

NUZ (ASX) Chart

Ann: Neurizon updates on NUZ-001 IND Application, page-391

'Not possible' to port renewable gas: ACCC takes AGN to court

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Neurizon updates on NUZ-001 IND Application, page-391

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News